FDA warns Curaleaf about inflated claims in CBD product marketing
5 years ago
18
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
2:02
WFTX
1 year agoTeachers fight for higher pay amid teacher shortage
7811 -
0:42
KMGH
2 years agoBBB warns about travel scams
56 -
0:43
KMGH
3 years agoBBB warns about counterfeit items
54 -
0:53
KMGH
3 years agoBBB warns about weight loss supplements
15 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
3 years agoFBI warns about popular Facebook scam
83 -
17:02
BIG NEM
12 hours agoHow I Befriended a 40 yr old VIRGIN
4.37K -
48:09
PMG
19 hours ago"Hannah Faulkner and Christie Hutcherson | WOMEN FIGHTING FOR AMERICA"
4.45K -
1:00:40
The Tom Renz Show
19 hours agoNo Security for Fauci & Was It Known That the mRNA COVID Vaccines Would Cause Cancer?
22.5K7